Table 4 from The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
AEs assessed as related to TempoCure, WBHT, or their combination and reported in three or more patients.
创建时间：
2026-02-04
相关数据集
暂无相关数据集
